NovaBay Pharmaceuticals Inc. Watch

from 8-K 5 pages Settlement Agreement and General and Mutual Release

from 8-K 6 pages Settlement Agreement and General and Mutual Release

from 8-K 17 pages Executive Employment Agreement

from 8-K 5 pages Amended and Restated Executive Employment Agreement

from 8-K 7 pages Voting Agreement

from 8-K 9 pages Warrant Exchange Agreement

from 8-K 9 pages Warrant Exchange Agreement

from 8-K 9 pages Warrant Exchange Agreement

from 8-K 44 pages Securities Purchase Agreement

from 8-K 9 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.] Confidential Settlement and Release Agreement

from 8-K 9 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.] Confidential Settlement and Release Agreement

from 8-K 9 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. the Redacted Terms Have Been Marked With the Following Marking: [Redacted.] Confidential Settlement and Release Agreement

from DEFA14A 10 pages 1. Purpose of Engagement. Lucid Will Provide Its Services to the Company as Its Financial Advisor Regarding a Potential Business Combination With an Unaffiliated Third Party (Referred to as a “Transaction”). This Transaction Could Take Various Forms, Including but Not Limited to Mergers, Consolidations, Reorganizations, Acquisitions, Recapitalizations, Stock Swaps, or Other Arrangements Through Which the Company May Be Acquired By, Acquire, or Merge With Another Entity. It Is Important to Note That a Transaction May Consist of Multiple Distinct Components (Such as Mergers, Spin-Offs, or Securities Issuance), Yet All Such Components Will Result in the Payment of a Single Transaction Fee (Defined Below) as Per the Terms of This Agreement. in Addition, (I) a Financing Transaction for the Purpose of Raising Cash or (II) a Liquidation and Dissolution of the Company, in Each Case, Shall Not Constitute a Transaction Nor Result in Any Payment of a Transaction Fee or Any Other Amount to Lucid Under This Agreement

from 8-K 10 pages 1. Purpose of Engagement. Lucid Will Provide Its Services to the Company as Its Financial Advisor Regarding a Potential Business Combination With an Unaffiliated Third Party (Referred to as a “Transaction”). This Transaction Could Take Various Forms, Including but Not Limited to Mergers, Consolidations, Reorganizations, Acquisitions, Recapitalizations, Stock Swaps, or Other Arrangements Through Which the Company May Be Acquired By, Acquire, or Merge With Another Entity. It Is Important to Note That a Transaction May Consist of Multiple Distinct Components (Such as Mergers, Spin-Offs, or Securities Issuance), Yet All Such Components Will Result in the Payment of a Single Transaction Fee (Defined Below) as Per the Terms of This Agreement. in Addition, (I) a Financing Transaction for the Purpose of Raising Cash or (II) a Liquidation and Dissolution of the Company, in Each Case, Shall Not Constitute a Transaction Nor Result in Any Payment of a Transaction Fee or Any Other Amount to Lucid Under This Agreement

from 8-K 2 pages Third Amendment to Executive Employment Agreement

from 8-K 4 pages Transition Services Agreement

from 8-K 9 pages Secured Promissory Note

from DEFA14A 9 pages Secured Promissory Note

from 8-K 18 pages Novabay Pharmaceuticals, Inc. and Equiniti Trust Company, LLC as Warrant Agent Warrant Agency Agreement Dated as of July 29, 2024 Warrant Agency Agreement

from 8-K 9 pages June 14, 2024 [●] Re: Warrant Exercise Agreement to Whom It May Concern